Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

DCPC 17695 - Enhanced Data Collection, Evaluation, and Analysis of Brain and Central Nervous System Malignant and non-Malignant Tumors

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract involves supporting the production and publication of the annual CBTRUS Statistical Report, which details primary brain and other central nervous system (CNS) tumors diagnosed in the United States from 2004 up to the most current available data. The scope includes conducting and publishing special reports on brain and CNS tumors, acting as subject matter experts in this area, and providing training and technical assistance specifically to CDC and NPCR award recipients. The contract emphasizes expertise in both malignant and non-malignant brain and CNS tumors, enhancing data collection, evaluation, and analysis to support these efforts. Issued by the Centers for Disease Control and Prevention, the contract is poised to advance knowledge and data dissemination concerning brain and CNS tumor statistics. It enables the continuation of vital epidemiological reporting and supports capacity building among relevant awardees through technical guidance and training. The contracting process appears to be forecasted rather than actively solicited, with key contacts identified for program and contracting communications, although certain details such as the place of performance and organization type remain unspecified.

General Info

Support annual CBTRUS report production, publish special tumor reports, provide CDC training and technical assistance.

Agency

Centers for Disease Control and Prevention → Centers For Disease Control And Prevention

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyCenters for Disease Control and Prevention → Centers For Disease Control And Prevention
Contacts2 people available
OfficeN/A
Organization / Agency
Centers for Disease Control and Prevention → Centers For Disease Control And Prevention
Office AddressN/A
Contacts
To Be Determined To Be DeterminedContracting Officer

Full Description

Show more
To support production and publication of the annual statistical report titled CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States for 2004 through the most current diagnosis year data are available, conduct and publish special reports on primary brain and CNS tumors, to serve as the primary brain and CNS tumor subject matter experts, and to provide training and technical assistance to CDC and NPCR award recipients.

Similar Contracts

NAICS: 541714
New
Federal
PAXGENE Ribonucleic acid extraction, quality control and aliquoting services​This contract is focused on procuring specialized laboratory services to support the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) clinical research activities. Specifically, it requires the extraction, quantitation, normalization, quality control, aliquoting, frozen storage, and shipment of ribonucleic acid (RNA) from 122 PAXgene tubes collected from 50 clinical participants. The services are essential for advancing gene expression profiling, molecular characterization of biospecimens, and subsequent transcriptomic analyses aimed at understanding disease mechanisms and therapeutic targets. The contractor must adhere to rigorous quality control standards, including performing DNase treatment to remove DNA contaminants, ensuring RNA integrity via Agilent instrumentation, and maintaining secure frozen storage conditions. They are also responsible for complete documentation and traceability throughout the processing stages and must notify NIDDK promptly if any specimen is compromised upon receipt. Additionally, the contractor will provide certificates of analysis, donor documentation, shipment records, and maintain the cold chain during storage and shipment. Regular communication with NIDDK personnel regarding order status and shipment tracking is also required to ensure smooth project execution. The contract is managed under the Department of Health and Human Services and will be performed in Maryland.
National Institutes Of Health Olao

POSTED

2 days ago

DEADLINE

in 9 days
View Details